论文部分内容阅读
目的:观察急诊经皮冠状动脉介入治疗对急性心肌梗死患者肝肾功能的影响。方法:入选因急性心肌梗死行急诊冠状动脉介入治疗的患者185例。入院即刻及出院前抽血查丙胺酸氨基转移酶(ALT)、血尿素氮(BUN)、肌酐(Cr)水平。对比分析因急性心肌梗死行急诊冠状动脉介入治疗的患者介入治疗前后肝肾功能的变化。结果:该组患者出院时较入院时的ALT、BUN、Cr水平无明显升高(P>0.05)。结论:急诊经皮冠状动脉介入治疗对急性心肌梗死患者的肝肾功能无明显的损害,是安全的。
Objective: To observe the effect of percutaneous coronary intervention on the liver and kidney function in patients with acute myocardial infarction. Methods: A total of 185 patients undergoing emergency PCI undergoing acute myocardial infarction were enrolled. Immediately before admission and before discharge from the hospital, blood levels of alanine aminotransferase (ALT), blood urea nitrogen (BUN) and creatinine (Cr) were measured. The changes of liver and kidney function before and after interventional treatment in patients undergoing emergency coronary interventional therapy by acute myocardial infarction were analyzed. Results: The levels of ALT, BUN and Cr in patients discharged from the hospital at the time of admission were not significantly higher (P> 0.05). Conclusion: Emergency percutaneous coronary intervention in patients with acute myocardial infarction in liver and kidney function without obvious damage, is safe.